STOCKHOLDERS’ EQUITY |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | NOTE D – STOCKHOLDERS’ EQUITY Stock Incentive Plan The Company adopted the 2022 Stock Incentive Plan, (the “2022 Plan”) upon approval by its Board of Directors on July 25, 2022 and its stockholders on September 20, 2022. The 2022 Plan provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted stock units. As of June 30, 2026, there were 125,000 shares of common stock subject to outstanding awards under the 2022 Plan and 1,920,000 shares of common stock available for issuance under the 2022 Plan.
Restricted Stock Units A summary of restricted stock unit activity for the three months ended June 30, 2026 is as follows (each restricted stock unit issued by the Company represents the right to receive one share of the Company’s common stock):
Restricted stock unit compensation expense was $ and $ for the three months ended June 30, 2026 and 2025, respectively. Restricted stock unit compensation expense was $ and $ for the six months ended June 30, 2026 and 2025, respectively. Stock-based compensation expense is included in general and administrative expenses in the unaudited condensed consolidated statements of operations. The Company had an aggregate of $ of unrecognized restricted stock unit compensation as of June 30, 2026 to be expensed over a weighted average period of approximately one year. All of the Company’s outstanding (unvested) restricted stock units have dividend equivalent rights. As of June 30, 2026 and December 31, 2025, there was $20,000 and $161,000, respectively, accrued for dividend equivalent rights which were included in other accrued expenses.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||